Making the latest Parkinson’s & dementia care accessible for all
Digital technology for clinicians, care givers & patients
Neu Health builds on 10 years of research and clinical validation by neurologists neuroscientists and data scientists from the University of Oxford, with the concept having been trialed and validated successfully in over 1,500 participants, and described in international, peer reviewed publications.
Parkinson’s disease, dementia and other neurodegenerative conditions are fast becoming the biggest causes of mortality and morbidity worldwide. By 2050, 200 million people are predicted to be living with these conditions.
Neu Health enables clinicians, care givers and patients to tackle this growing challenge with cutting-edge digital technologies designed to make the latest care accessible for all, improving outcomes today and accelerating future breakthroughs.
Right care, at the right time
Our innovative smartphone-based platform and patient programme is designed to monitor and translate digital measures of clinically relevant symptoms – optimising condition management, reducing clinician burden and ultimately improving outcomes.
Patient-centric app-based remote monitoring of disease progression, requiring just 7 minutes of patient input
Artificial intelligence/machine learning and analytics to accurately measure progression and predicting significant clinical outcomes 18 months in advance
Remote clinician-guided management, optimising access to clinical care
Improved medication management based on real-time clinical changes allowing informed adaptive clinical decision making
Reassurance and education for patients and carers between clinical visits
In-person and digital therapies, matched to patient needs
Neu Health supports people living with Parkinson’s disease and Dementia, helping them to live independently, stay at home longer and reduce their need for higher acuity care.
